Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthofix Medical (OFIX) Capital Expenditures (2016 - 2025)

Orthofix Medical (OFIX) has disclosed Capital Expenditures for 16 consecutive years, with $10.9 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Capital Expenditures rose 27.5% year-over-year to $10.9 million, compared with a TTM value of $34.6 million through Dec 2025, down 0.72%, and an annual FY2025 reading of $34.6 million, down 0.72% over the prior year.
  • Capital Expenditures was $10.9 million for Q4 2025 at Orthofix Medical, up from $9.9 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $21.9 million in Q3 2023 and bottomed at $2.5 million in Q3 2021.
  • Average Capital Expenditures over 5 years is $8.6 million, with a median of $7.1 million recorded in 2022.
  • The sharpest move saw Capital Expenditures soared 326.6% in 2023, then crashed 73.43% in 2024.
  • Year by year, Capital Expenditures stood at $6.2 million in 2021, then increased by 12.47% to $7.0 million in 2022, then soared by 133.61% to $16.4 million in 2023, then plummeted by 47.84% to $8.5 million in 2024, then rose by 27.5% to $10.9 million in 2025.
  • Business Quant data shows Capital Expenditures for OFIX at $10.9 million in Q4 2025, $9.9 million in Q3 2025, and $7.1 million in Q2 2025.